Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Value of HTC settlement

I was at a SHM when it was softly spoken by the BOD and acknowledged by DL that the issue of patent extension time had been remedied. They would not go into details when asked but all of them (and I saw their faces) were smiling. Others have commented on it as well. It wasn’t just my imagination. So, if what they acknowledged and smiled about is true, then where is the argument for a short revenue lifespan?

I believe it has been confirmed there will be no extension applications by PTSC/CM/TPL for any patents.. why not I do not know..

Share
New Message
Please login to post a reply